Switch theme
Sign up to access all valuation multiples
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
2009
184
LTM Revenue $9.0M
LTM EBITDA -$59.9M
$152M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nyxoah has a last 12-month revenue of $9.0M and a last 12-month EBITDA of -$59.9M.
In the most recent fiscal year, Nyxoah achieved revenue of $4.9M and an EBITDA of -$56.7M.
Nyxoah expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nyxoah valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.7M | $4.9M | XXX | XXX | XXX |
| Gross Profit | $2.1M | $2.9M | XXX | XXX | XXX |
| Gross Margin | 44% | 60% | XXX | XXX | XXX |
| EBITDA | -$45.2M | -$56.7M | XXX | XXX | XXX |
| EBITDA Margin | -968% | -1169% | XXX | XXX | XXX |
| Net Profit | -$33.5M | -$46.4M | XXX | XXX | XXX |
| Net Margin | -718% | -956% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Nyxoah's stock price is EUR 5 (or $6).
Nyxoah has current market cap of EUR 204M (or $219M), and EV of EUR 141M (or $152M).
See Nyxoah trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $152M | $219M | XXX | XXX | XXX | XXX | $-1.99 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Nyxoah has market cap of $219M and EV of $152M.
Nyxoah's trades at 16.8x LTM EV/Revenue multiple, and -2.5x LTM EBITDA.
Analysts estimate Nyxoah's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nyxoah and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $152M | XXX | XXX | XXX |
| EV/Revenue | 31.3x | XXX | XXX | XXX |
| EV/EBITDA | -2.7x | XXX | XXX | XXX |
| P/E | -3.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -2.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNyxoah's NTM/LTM revenue growth is 246%
Nyxoah's revenue per employee for the last fiscal year averaged $26K, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Nyxoah's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nyxoah's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nyxoah and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -1169% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -923% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $26K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 601% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 761% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 1366% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nyxoah acquired XXX companies to date.
Last acquisition by Nyxoah was XXXXXXXX, XXXXX XXXXX XXXXXX . Nyxoah acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Nyxoah founded? | Nyxoah was founded in 2009. |
| Where is Nyxoah headquartered? | Nyxoah is headquartered in Belgium. |
| How many employees does Nyxoah have? | As of today, Nyxoah has 184 employees. |
| Who is the CEO of Nyxoah? | Nyxoah's CEO is Mr. Olivier Taelman. |
| Is Nyxoah publicy listed? | Yes, Nyxoah is a public company listed on BRU. |
| What is the stock symbol of Nyxoah? | Nyxoah trades under NYXH ticker. |
| When did Nyxoah go public? | Nyxoah went public in 2020. |
| Who are competitors of Nyxoah? | Similar companies to Nyxoah include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nyxoah? | Nyxoah's current market cap is $219M |
| What is the current revenue of Nyxoah? | Nyxoah's last 12-month revenue is $9.0M. |
| What is the current EBITDA of Nyxoah? | Nyxoah's last 12-month EBITDA is -$59.9M. |
| What is the current EV/Revenue multiple of Nyxoah? | Current revenue multiple of Nyxoah is 16.8x. |
| What is the current EV/EBITDA multiple of Nyxoah? | Current EBITDA multiple of Nyxoah is -2.5x. |
| What is the current revenue growth of Nyxoah? | Nyxoah revenue growth between 2023 and 2024 was 4%. |
| Is Nyxoah profitable? | Yes, Nyxoah is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
